Xing Xie (Xie Xing)

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 19

Top Topics

Endometrial Cancer

Top Venues

Journal of gynecologic oncology

BMC women's health

Cancer management and research

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yuanyuan Liu, Yaqiong Ye, Xiaodong Cheng, Weiguo Lü, Xing Xie, Xinyu Wang, Xiao Li
The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia. BMC women's health 23 (1) (2023)
Yuanyuan Liu, Yaqiong Ye, Xiaodong Cheng, Weiguo Lü, Xing Xie, Xinyu Wang, Xiao Li
The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia. BMC women's health 23 (1) (2023)
Yuanyuan Liu, Yaqiong Ye, Xiaodong Cheng, Weiguo Lü, Xing Xie, Xinyu Wang, Xiao Li
The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia. BMC women's health 23 (1) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology 34 (2) (2023)
Qianqian Pan, Mingjing Wei, Mengyi Lu, Yaping Xu, Xing Xie, Xiao Li
The Role of Perioperative C-Reactive Protein in Predicting the Prognosis of Epithelial Ovarian Carcinoma. Cancer management and research 15 (2023)
Yuanyuan Liu, Yaqiong Ye, Xiaodong Cheng, Weiguo Lü, Xing Xie, Xinyu Wang, Xiao Li
The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia. BMC women's health 23 (1) (2023)
Qianqian Pan, Mingjing Wei, Mengyi Lu, Yaping Xu, Xing Xie, Xiao Li
The Role of Perioperative C-Reactive Protein in Predicting the Prognosis of Epithelial Ovarian Carcinoma. Cancer management and research 15 (2023)
Yang Li, Changkun Zhu, Hongyu Xie, Yaxia Chen, Wei-Guo Lv, Xing Xie, Xinyu Wang
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT). Journal of gynecologic oncology (2023)
Jiaying Wang, Conghui Wang, Yang Li, Mingyue Li, Tingjia Zhu, Zhangjin Shen, Hui Wang, Weiguo Lv, Xinyu Wang, Xiaodong Cheng, Xing Xie
Potential of peptide-engineered exosomes with overexpressed miR-92b-3p in anti-angiogenic therapy of ovarian cancer. Clinical and translational medicine 11 (5) (2022)
Conghui Wang, Jiaying Wang, Xiameng Shen, Mingyue Li, Yongfang Yue, Xiaodong Cheng, Weiguo Lu, Xinyu Wang, Xing Xie
LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Yingmei Wang, Shiqian Zhang, Lihui Wei, Zhong-Qiu Lin, Xinyu Wang, Jianliu Wang, Ke-Qin Hua, Man-Hua Cui, Jiandong Wang, Shixuan Wang, Wen Di, Yu-Dong Wang, Ruifang An, Mingrong Xi, Ruixia Guo, Qi Zhou, Xing Xie, Feng-Xia Xue
Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists. Journal of gynecologic oncology 31 (4) (2020)
Yongfang Yue, Lili Xia, Shanshan Xu, Conghui Wang, Xinyu Wang, Weiguo Lü, Xing Xie
SURF4 maintains stem-like properties via BIRC3 in ovarian cancer cells. Journal of gynecologic oncology 31 (4) (2020)
Xiaodong Wu, Jiale Qin, Tao Shen, Weidong Fei, Lili Chen, Xing Xie, Wei-Guo Lv
The 16-year experience in treating low-risk gestational trophoblastic neoplasia patients with failed primary methotrexate chemotherapy. Journal of gynecologic oncology 31 (4) (2020)
Chen Tingting, Yang Shizhou, Zhang Songfa, Xu Junfen, Lu Weiguo, Cheng Xiaodong, Xing Xie
Human papillomavirus 16E6/E7 activates autophagy via Atg9B and LAMP1 in cervical cancer cells. Cancer medicine 8 (9) (2019)
Xiao Li, Yaping Xu, Yuanyuan Liu, Xiaodong Cheng, Xinyu Wang, Weiguo Lü, Xing Xie
The management of hydatidiform mole with lung nodule: a retrospective analysis in 53 patients. Journal of gynecologic oncology 30 (2) (2018)
Qiongyan Wu, Xiumin Zhao, Yunfeng Fu, Xinyu Wang, Xiaofei Zhang, Xun Tian, Bei Cheng, Bingjian Lu, Xiao Yu, Suqiu Lan, Weiguo Lu, Ding Ma, Xiaodong Cheng, Xing Xie
A cross-sectional study on HPV testing with type 16/18 genotyping for cervical cancer screening in 11,064 Chinese women. Cancer medicine 6 (5) (2017)